Why Apple App Store Compliance Is Different
A note before anything else. This is general information from a pharmacist who has been through this build, not legal advice or regulatory advice, and it does not create a professional relationship. Apple revises the App Store Review Guidelines several times a year and does renumber sections, so treat every guideline number below as a pointer and read the current text at developer.apple.com/app-store/review/guidelines before you rely on it. The guideline text described here was checked in September 2026. Where your app's FDA status, privacy obligations or scope of practice are in question, get a regulatory attorney to look at your actual product.
The Apple App Store has some of the most specific and strictly enforced guidelines for health applications of any distribution platform. Apps that fail to meet these guidelines are rejected during review, and the review process can take days or weeks. Understanding the requirements before you build saves significant time and rework.
The two guidelines that matter most for health education apps are 1.4.1 (medical apps under Physical Harm) and 5.1.3 (Health and Health Research). If your app calculates a drug dose in any form, a third one applies and it is the strictest of the set. Guideline 1.4.2 requires that drug dosage calculators come from the drug manufacturer, a hospital, university, health insurance company, pharmacy or other approved entity, or receive approval from the FDA or one of its international counterparts. Credentials alone do not clear this bar. A licensed pharmacist building a dosing calculator as an individual, outside one of those entities, should expect rejection. Anything that outputs a dose, including a unit conversion or a taper schedule, is worth treating as in scope.
Guideline 1.4.1: Medical Apps
Guideline 1.4.1 states that medical apps which could provide inaccurate data or information, or that could be used for diagnosing or treating patients, may be reviewed with greater scrutiny. It also carries a flat prohibition that matters here. Apps that claim to take x-rays, or to measure blood pressure, body temperature, blood glucose levels, or blood oxygen levels using only the sensors on the device, are not permitted. Logging a reading the user took on their own validated device is fine. Deriving that reading from the phone camera or phone sensors is not. What 1.4.1 actually asks for is different. If your medical app has received regulatory clearance, submit a link to that documentation with your app. It does not ask for a letter or credential from a licensed clinician. If you have no clearance because your app is not a device, you have nothing to submit here, and that is a normal position to be in.
The key phrase is "intended to provide medical diagnoses or treatment recommendations." An app that is clearly educational in nature, with appropriate disclaimers, has a much stronger case that it is not intended to provide medical diagnoses. It is a case, not a guarantee. Both Apple and the FDA read intended use from what the app claims and what it actually does, and a disclaimer does not undo a feature that hands the user a clinical conclusion. The intent is established by the app's name, description, UI language, and the disclaimers present in the app.
Practical implications:
- The app name and description must clearly indicate educational intent
- The UI must not use diagnostic language
- Disclaimers must be present and prominent
- Any health metrics displayed must be framed as educational reference points, and any accuracy claim attached to a health measurement must come with a clear disclosure of the underlying data and methodology. Apple rejects apps whose accuracy or methodology cannot be validated
- The app should remind users to check with a doctor in addition to using the app and before making medical decisions
Guideline 5.1.3: Health and Health Research
Guideline 5.1.3 covers apps that collect health data. One requirement shapes your storage decision before you write a line of code: under 5.1.3(ii), apps must not write false or inaccurate data into HealthKit or any other medical research or health management app, and may not store personal health information in iCloud. If your plan was iCloud sync for user health records, change it now. That is an architecture decision, not a review-time fix.
The other key requirements:
The requirement to secure user consent before collecting user or usage data lives in 5.1.1(ii), and it applies whether or not the data is health data. What 5.1.3(i) adds on top is a restriction on where health data can go. You may not use or disclose to third parties data gathered in the health, fitness and medical research context for advertising, marketing or other use-based data mining. 5.1.3(i) also carries a disclosure duty that is easy to miss: you must disclose the specific health data you are collecting from the device.
Apps must not use health data for advertising or data mining. This means your analytics and advertising integrations must not have access to health data.
If your app conducts health-related human subject research, 5.1.3 gets much heavier. Under 5.1.3(iii) you must obtain consent from participants, or from a parent or guardian for minors, covering five specific things: the nature, purpose and duration of the research; the procedures, risks and benefits; how data is kept confidential and handled including any third party sharing; a point of contact for participant questions; and the withdrawal process. Under 5.1.3(iv) you must secure approval from an independent ethics review board, and Apple can ask you to produce proof of it. This is the most common way an educator app crosses a line it did not know was there. Collecting outcome data across a cohort so you can write it up is research. Get the ethics review before you build, not after a rejection.
The privacy policy requirement is 5.1.1(i), not 5.1.3, and it is more demanding than most first drafts. You need a link to the policy in your App Store Connect metadata and inside the app in an easily accessible place. The policy has to identify what data you collect and how, confirm that any third party you share it with gives it the same protection your policy promises, and explain your retention and deletion policy including how a user revokes consent or requests deletion. Under 5.1.1(v), if your app supports account creation you must also offer account deletion from inside the app.
The PWA-First Strategy
For health education apps that are in early development, the Progressive Web App (PWA) approach makes sense for two reasons.
First, PWAs bypass the App Store review process entirely. A PWA is accessed through the browser, not the App Store. This allows you to launch, iterate, and gather user feedback without waiting for App Store approval.
Second, PWAs can be converted to native apps using tools like Capacitor once the app is stable and you are ready for App Store submission. The PWA serves as a working prototype that demonstrates the app's functionality and compliance posture to Apple reviewers.
The Hunters Holistic Health platform launched as a PWA. The App Store submission is a Phase 2 milestone, after the PWA has been tested with real users and the compliance posture has been validated.
The Consent Architecture
For App Store compliance, the consent architecture must be explicit. Here is the pattern used in Hunters Holistic Health:
On first launch, before any health data collection, the app displays a consent screen that explains:
- What data is collected (daily logs, meal descriptions)
- How it is used (educational tracking and progress visualization)
- Who can see it (the user and their educator)
- How to delete it (account deletion removes all data within 30 days)
- That the data is not used for advertising or shared with third parties
The user must actively consent (tap "I Agree") before proceeding. The consent is logged with a timestamp in Supabase.
This consent architecture is built to line up with Apple's requirements under 5.1.1(ii) and 5.1.3, and it is a reasonable starting point for GDPR and CPRA conversations. It does not by itself make you compliant with either law. GDPR treats health data as a special category with its own lawful basis requirement, and CPRA has a separate regime for sensitive personal information. Both reach well past the consent screen into rights handling, retention, vendor terms and cross-border transfers. Have a privacy attorney review your actual data flows before you tell users you are compliant with anything.
The Disclaimer Architecture
For Guideline 1.4.1 compliance, disclaimers must be present in multiple places:
- The App Store listing description
- The app's onboarding flow (before first use)
- The settings page
- Any screen that displays health metrics
- The Terms of Service
The disclaimer language: "This app is for educational purposes only. It does not provide medical advice, diagnosis, or treatment. The information provided is not a substitute for professional medical advice. Always consult your healthcare provider before making health decisions."
The HealthKit Decision
Apple HealthKit integration is a significant compliance consideration. Apps that integrate with HealthKit are subject to additional review scrutiny and must comply with specific HealthKit usage requirements.
For a Phase 1 launch, HealthKit integration is not recommended. The added review complexity and the requirement to handle HealthKit data according to Apple's strict guidelines creates unnecessary risk during the initial launch phase.
HealthKit integration is a Phase 2 feature, after the app has been approved and is stable. At that point, the integration can be added incrementally with a focused review of the HealthKit-specific requirements.
The Takeaway
Apple App Store compliance for health apps requires attention to four areas: educational intent in the app name and description, no diagnostic language in the UI, explicit consent before health data collection, and prominent disclaimers throughout the app.
Clearing all four does not settle your FDA position, and this is where readers most often get confused. Apple and the FDA are separate gates with separate tests. Passing App Review is not an FDA determination and gives your app no regulatory status. The FDA question is whether your intended use makes the software a device. FDA's General Wellness policy keeps a product outside device regulation when it is intended for maintaining or encouraging a healthy lifestyle and is unrelated to the diagnosis, cure, mitigation, prevention or treatment of a disease or condition. It is your claims that push you across, not your code. Under FDA's device software function policy, apps that let users log and track their own health measurements, and apps that help users self-manage a condition without offering specific treatment suggestions, generally sit in enforcement discretion. Apps that produce a diagnosis or drive a treatment decision are devices. The same disease-claim language that pulls you into FDA device territory is what triggers greater scrutiny from Apple under 1.4.1, so the two gates fail together for the same reason.
The PWA-first strategy allows you to launch and iterate without App Store review constraints. When you are ready for App Store submission, the compliance architecture built into the PWA translates directly to the native app.